Röchling Medical has very strong expertise and capabilities in supporting – through our own R&D department – our customers on the development of their Drug Delivery Systems. Driven by Innovation as a core competence within the Group Divisions (Automotive, Industrial, Medical), Röchling Medical will employ cutting edge technology for development & manufacturing of products to ensure superior and cost effective solutions for our customers.
The first aspect of the Co-development will be to establish the input requirements based on:
A Use Failure Modes and Effect Analysis (Use FMEA) will be drafted.
Next step will be to develop overall concepts (by using QFD matrix, Six sigma for design) until a single concept (or a limited selection) is shown to reduce all the identified risks to a reasonable level. The Use FMEA and the Product Requirements Document will be updated and a Design FMEA drafted.
Development of the System will follow our NPI (New Product Innovation) procedure and will include:
Our Project Team will be engaged & committed to deliver on its promises within agreed deadlines with our clients.